Clinigen revenue rises as shareholders approve its acquisition
23rd Feb 2022 13:28
(Sharecast News) - Pharmaceuticals and service company Clinigen Group reported a 10% improvement in net revenue from continuing operations in its half-year results on Wednesday, or 14% on an organic basis, to £238.1m.
Read moreTriton makes 'increased and final' 925p bid for Clinigen
17th Jan 2022 07:29
(Sharecast News) - Clinigen announced an increased and final all-cash offer from Triton of 925p per share on Monday.
Read moreClinigen reiterates guidance after 'solid' first half
12th Jan 2022 11:49
(Sharecast News) - Pharmaceutical products and services company Clinigen reiterated its guidance for EBITDA growth in the 2022 financial year of between 5% and 10% in a trading update on Wednesday.
Read moreClinigen to be taken private by Triton in £1.2bn deal, shares surge
8th Dec 2021 08:16
(Sharecast News) - Clinigen surged on Wednesday after agreeing to be taken private by European investment firm Triton in a £1.2bn deal.
Read moreClinigen confirms takeover talks with Triton, shares surge
2nd Dec 2021 12:59
(Sharecast News) - Clinigen shares surged on Thursday after the company confirmed it has received a non-binding indicative proposal from investment firm Triton about a possible offer.
Read moreLiberum lowers target price on Clinigen
5th Nov 2021 09:55
(Sharecast News) - Analysts at Liberum lowered their target price on pharmaceutical services and products group Clinigen from 886.0p to 800.0p on Friday but stated risks still appeared to be "skewed to the upside".
Read moreClinigen to distribute 'Copiktra' in most of Europe
22nd Sep 2021 13:34
(Sharecast News) - Pharmaceutical products and services provider Clinigen has signed an exclusive agreement with Secura Bio for the supply and distribution of 'Copiktra' in most of Europe, it announced on Wednesday.
Read moreClinigen cuts full-year earnings forecasts, shares fall
16th Sep 2021 12:29
(Sharecast News) - Shares in Clinigen Group fell on Thursday after the pharmaceuticals specialist cut its full-year earnings forecast.
Read moreAllen out, Schnee in as Cliningen board chairman
1st Sep 2021 09:12
(Sharecast News) - Pharmaceutical products and services company Clinigen announced on Wednesday that non-executive director and chairman-designate Elmar Schnee was becoming chairman with immediate effect.
Read moreClinigen CFO Nick Keher steps down
25th Aug 2021 07:34
(Sharecast News) - Pharmaceutical group Clinigen said on Wednesday that chief financial officer Nick Keher has stepped down with immediate effect "to pursue other business interests".
Read moreClinigen inks partnership agreement with Eyevance Pharmaceuticals
5th Aug 2021 10:45
(Sharecast News) - Pharmaceutical firm Clinigen said on Thursday that it has inked an exclusive partnership agreement with Eyevance Pharmaceuticals, a wholly-owned subsidiary of Santen Pharmaceutical.
Read moreWednesday broker round-up
14th Jul 2021 13:23
(Sharecast News) - Carnival: Berenberg upgrades to hold with a target price of 1,400p.
Read moreClinigen ends year in line with expectations
13th Jul 2021 09:36
(Sharecast News) - Pharmaceutical products and services company Clinigen updated the market on its just-ended financial year on Tuesday, saying net revenue was expected to be £455m, representing an increase of 12% on both a constant currency and organic basis.
Read moreSunday share tips: Clinigen, UK companies
11th Jul 2021 18:55
(Sharecast News) - The Sunday Times's Sabah Meddings told readers to 'hold' shares of Clinigen amid some resurgent 'market chatter' regarding a possible bid emerging for the medicines supplier.
Read moreClinigen to sell UK specials business for up to £7.8m
30th Jun 2021 13:07
(Sharecast News) - Pharmaceutical company Clinigen has agreed the disposal of its non-core UK specials manufacturing and aseptic compounding business to Target Healthcare for up to £7.75m.
Read more